![Marcio Souza](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 20 M $ in data 31/08/2026
Marcio Souza is President, Chief Executive Officer & Director at Praxis Precision Medicines, Inc. since 2020.
Mr. Souza is Director at Remagine Labs, Inc. Former roles include Executive Director-Marketing at NPS Pharmaceuticals, Inc. from 2012 to 2014, Independent Director at Spyre Therapeutics, Inc. from 2021 to 2023, Independent Director at ClearPoint Neuro, Inc. in 2020, Director at ClearPoint Neuro, Inc., and Chief Operating Officer at PTC Therapeutics, Inc. from 2017 to 2020.
Education includes an MBA from Fundação Dom Cabral and undergraduate studies at the University of Sao Paulo.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/07/2026 | 56.495 ( 0,2% ) | 20 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Amministratore Delegato | 01/04/2020 |
| Società | Posizione | Fine |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/06/2023 |
| CLEARPOINT NEURO, INC. | Direttore/Membro del Consiglio | 27/04/2020 |
| PTC THERAPEUTICS, INC. | Direttore operativo | 01/04/2020 |
| NPS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2014 |
| CLEARPOINT NEURO, INC. | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Fundação Dom Cabral
 Fundação Dom Cabral Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Sao Paulo
 University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clearpoint Neuro, Inc.
 Clearpoint Neuro, Inc. Medical SpecialtiesHealth Technology Develops and markets bio technology and surgical products | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
